“Big pharma… victims of their own success?” (Part 2 of 2)
10/11/24 • 21 min
In the first episode about patient-centricity transformation, Torsten outlined how to shift the hearts, minds and hands of people in the organization. This episode continues the conversation and focuses on shaping the organizational structure and operating model to support patient centricity. Specifically, the need to break with traditional, and often successful, ways of operating, as well as the approaches and models organizations can adopt. This conversation is based on chapter 10, “Transforming to a Patient-Centric Organization.”
Featuring: Torsten Bernewitz, principal emeritus at ZS. Torsten created and led ZS’s global change management expertise center.
Produced by Samantha Keyes and Georgianna Moreland
In the first episode about patient-centricity transformation, Torsten outlined how to shift the hearts, minds and hands of people in the organization. This episode continues the conversation and focuses on shaping the organizational structure and operating model to support patient centricity. Specifically, the need to break with traditional, and often successful, ways of operating, as well as the approaches and models organizations can adopt. This conversation is based on chapter 10, “Transforming to a Patient-Centric Organization.”
Featuring: Torsten Bernewitz, principal emeritus at ZS. Torsten created and led ZS’s global change management expertise center.
Produced by Samantha Keyes and Georgianna Moreland
Previous Episode
"Patients in their own words" -- Nathan's story
Nathan Peck is the CEO of Cure VCP Disease, a VCP disease patient, husband and father.
Nathan possesses a Bachelor of Industrial Engineering from the Georgia Institute of Technology as well as an MBA and Masters of Civil and Environmental Engineering from the Massachusetts Institute of Technology. As a patient, in January 2018, he formed Cure VCP Disease, Inc. along with a passionate group of IBMPFD patients, caregivers and researchers. Through Cure VCP Disease, Inc. he is committed to bringing together patients, caregivers, researchers, pharmaceutical companies, other non-profits and investors to identify treatments and ultimately a cure for this ultra-rare, genetic disease. Being a patient with the disease drives the organization’s urgency and purpose.
In Nathan’s own words, “our goal is to make Cure VCP disease extinct... I don't want this organization to become big and long lasting. I want it to die because we conquered the disease, and we helped others in the process.”
See below for more information on Cure VCP Disease:
Website: https://www.curevcp.org/
What is VCP disease: https://youtu.be/behsJnCjbrk
Help support Cure VCP Disease: https://givebutter.com/2023VCPScientificProgram
Email: [email protected]
Produced by Samantha Keyes and Georgianna Moreland
Next Episode
“A patient centric launch doesn’t have to involve a commercial”
Host, Victoria Summers, welcomes colleague Emily Mandell to discuss how a patient centric approach can work to ensure that patients get the right diagnosis and the right treatment more effectively. The conversation also covers what a patient centric product launch looks like and how the industry is continuing to evolve to improve patient outcomes. This conversation is based on chapter 7, “If You Launch It, They Will Come ... Or Will They?”
Featuring: Emily Mandell, principal at ZS and leader of ZS’s global pipeline and launch strategy practice.
Produced by Samantha Keyes and Georgianna Moreland
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/patient-centricity-471929/big-pharma-victims-of-their-own-success-part-2-of-2-63518824"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to “big pharma… victims of their own success?” (part 2 of 2) on goodpods" style="width: 225px" /> </a>
Copy